Olaf B. Paulson

Medicine & Life Sciences

1. altanserin 38%
2. Amygdala 21%
3. Angiotensin Receptor Antagonists 17%
4. Anisotropy 20%
5. Artifacts 18%
6. Atrophy 22%
7. Blindness 22%
8. Blood-Brain Barrier 19%
9. Brain 99%
10. candesartan 17%
11. Cerebral Blood Volume 20%
12. Cerebrovascular Circulation 99%
13. Citalopram 40%
14. Cognitive Dysfunction 20%
15. Depression 32%
16. Electroconvulsive Therapy 47%
17. Erythropoietin 33%
18. Flumazenil 17%
19. Glucocorticoids 23%
20. Glucose 17%
21. Gray Matter 30%
22. Healthy Volunteers 32%
23. Hereditary Spastic Paraplegia 18%
24. Hippocampus 23%
25. Homeostasis 25%
26. Longitudinal Studies 30%
27. Magnetic Resonance Imaging 100%
28. Memory 28%
29. Mood Disorders 29%
30. Motor Cortex 22%
31. Multiple Sclerosis 46%
32. N-acetylaspartate 22%
33. Neuroticism 17%
34. Occipital Lobe 24%
35. Ocular Vision 17%
36. Photic Stimulation 18%
37. Positron-Emission Tomography 46%
38. Postoperative Cognitive Complications 18%
39. Prefrontal Cortex 38%
40. Psychology Recognition 22%
41. Receptor, Serotonin, 5-HT2A 66%
42. Regional Blood Flow 50%
43. Serotonin 28%
44. Temporal Lobe 35%
45. Thoracic Surgery 23%
46. Transcranial Magnetic Stimulation 21%
47. Traumatic Brain Injury 25%
48. Visual Cortex 40%
49. Visual Pathways 17%
50. White Matter 49%